Form 4 for NEPH NEPHROS INC
Accepted 2026-03-25 00:00:00 ET · period of report 2026-03-23 · accession 0000914190-26-000053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-25 | 2026-03-23 | NEPH | Banks Robert R. Jr. | Pres, CEO | M - OptEx | $1.44 | +120.0K | 190.0K | +171% | +$172.8K |
| D | 2026-03-25 | 2026-03-23 | NEPH | Banks Robert R. Jr. | Pres, CEO | M - OptEx | $0.00 | -120.0K | 237.2K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-23 | M | A | 120,000 | $1.44 | 190,000 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2026-03-23 | M | D | 120,000 | $0.00 | 237,165 | D | $1.44 · — to 2033-05-05 | 120,000 Common Stock | (F1) Options to purchase 89,291 shares vest on 5/5/24 and options to purchase 267,874 shares vest quarterly in 12 equal amounts commencing on 8/5/24. |